Residual tumor in cases of intermediate-risk neuroblastoma did not influence the prognosis.
Jpn J Clin Oncol. 2016 Jul;46(7):661-6
Authors: Iehara T, Yagyu S, Tsuchiya K, Kuwahara Y, Miyachi M, Tajiri T, Sugimoto T, Sawada T, Hosoi H
Abstract BACKGROUND: It remains unclear whether a residual tumor mass following therapy influences the prognosis of neuroblastoma.